Bridgefront Capital’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-28,205	Closed	-$183K	–	868
2025 Q1	$183K	Buy	+28,205	New	+$183K	0.05%	533
2024 Q3	–	Sell	-15,751	Closed	-$140K	–	729
2024 Q2	$140K	Buy	+15,751	New	+$140K	0.06%	437